Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review)

Por Wyganowska-Świątkowska, Marzena, Tarnowski, Mateusz, Murtagh, Daniel, Skrzypczak-Jankun, Ewa, Jankun, Jerzy
Publicado no Int J Mol Med (2019)

Neoadjuvant chemotherapy for high‐risk prostatic adenocarcinoma

Por Brunner, Robert, Buck, Bradley, Giffen, Zane, Murtagh, Daniel, Lewis, Terrence, Gatto‐Weis, Cara, Sindhwani, Puneet
Publicado no IJU Case Rep (2019)

A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients

Por Brikun, Igor, Nusskern, Deborah, Gillen, Daniel, Lynn, Amy, Murtagh, Daniel, Feczko, John, Nelson, William G, Freije, Diha
Publicado no Biomark Res (2014)